<SEC-DOCUMENT>0000731766-24-000023.txt : 20240112
<SEC-HEADER>0000731766-24-000023.hdr.sgml : 20240112
<ACCEPTANCE-DATETIME>20240112060127
ACCESSION NUMBER:		0000731766-24-000023
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240112
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240112
DATE AS OF CHANGE:		20240112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		24530500

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>unh-20240112.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2024 Workiva--><!--r:b197cb2c-d9a5-468e-9558-8fe9510c2889,g:0c0038cb-9400-4966-a322-d321c163fdbd,d:c324fa16c2ff4c71852156fc9f2f9698--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>unh-20240112</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000731766</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="unh-20240112.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000731766</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-12</xbrli:startDate><xbrli:endDate>2024-01-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic324fa16c2ff4c71852156fc9f2f9698_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Current Report </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934 </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of report (Date of earliest event reported):  <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">January 12, 2024</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">UNITEDHEALTH GROUP INCORPORATED</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.584%"><tr><td style="width:1.0%"></td><td style="width:15.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">1-10864</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">41-1321939</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Commission File Number)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.654%"><tr><td style="width:1.0%"></td><td style="width:59.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">UnitedHealth Group Center, 9900 Bren Road East,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Minnetonka,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Minnesota</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">55343</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">952</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">936-1300</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report.) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:33.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, $.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">UNH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings 2',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ic324fa16c2ff4c71852156fc9f2f9698_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 12, 2024, UnitedHealth Group Incorporated (the &#8220;Company&#8221;) issued a press release announcing its fourth quarter and full year 2023 results.  A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information in this Item 2.02 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Exhibits.</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023q4exhibit991.htm">99.1</a></span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2023q4exhibit991.htm">Press Release dated January 12, 2024</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: January 12, 2024 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.134%"><tr><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.259%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UNITEDHEALTH GROUP INCORPORATED</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ Kuai H. Leong</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kuai H. Leong</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deputy Corporate Secretary</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a2023q4exhibit991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic91fe566cc574b2d96ca6eb54d06beb6_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><img alt="uhglogoa.jpg" src="uhglogoa.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:408px"></div><div style="margin-top:30pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:112%">UnitedHealth Group Reports 2023 Results</font></div><div style="padding-left:216pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.15pt">Revenues of $371.6 Billion Grew 15% Year-Over-Year</font></div><div style="padding-left:252pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.15pt">Earnings from Operations Grew 14%</font></div><div style="padding-left:252pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.15pt">Cash Flows from Operations were $29.1 Billion or 1.3x Net Income</font></div><div style="padding-left:252pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.15pt">Full Year and Fourth Quarter Net Earnings were $23.86 and $5.83 Per Share</font></div><div style="padding-left:252pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:150%;padding-left:14.15pt">Full Year and Fourth Quarter Adjusted Net Earnings were $25.12 and $6.16 Per Share</font></div><div style="margin-top:15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:150%">(January 12, 2024)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> UnitedHealth Group (NYSE&#58; UNH) reported full year and fourth quarter 2023 results reflecting broad-based growth at Optum and UnitedHealthcare. </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8220;UnitedHealth Group enters 2024 well prepared to build on our efforts to improve patient care and consumer experiences broadly, and to continue delivering strong and balanced growth,&#8221; said Andrew Witty, chief executive officer of UnitedHealth Group.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">UnitedHealth Group affirmed the 2024 performance objectives established at its November 29</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:150%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> Investor Conference, excluding the potential impacts from the pending sale of its Brazil operations, which is expected to close in the first half of 2024. Upon closing, the Company&#8217;s net earnings outlook will be impacted by the previously announced expected charge and the Company confirmed the adjusted earnings outlook presented at its Investor Conference. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 1 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><img alt="uhglogoa.jpg" src="uhglogoa.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:408px"></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:500.25pt"><tr><td style="width:1.0pt"></td><td style="width:145.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly and Annual Financial Performance</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="6" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</font></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$94.4 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$82.8 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$92.4 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$371.6 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$324.2 billion</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.7 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.9 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.5 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32.4 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28.4 billion</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2%</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:15pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">UnitedHealth Group&#8217;s 2023 revenues grew $47.5 billion or 14.6% year-over-year to $371.6 billion, including double-digit growth at both Optum and UnitedHealthcare, driven by serving more people, more comprehensively across its offerings. Full year 2023 earnings from operations were $32.4 billion, an increase of 13.8%.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">The full year medical care ratio at 83.2% compared to 82% last year, driven by previously noted outpatient care, primarily serving seniors, and business mix. The fourth quarter medical care ratio was 85%. Days claims payable of 47.9 compared to 49.9 at year end 2022 and 50.7 in the third quarter 2023. Medical reserve development was $840 million favorable for full year 2023 and $100 million unfavorable in the fourth quarter.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">The full year 2023 operating cost ratio of 14.7% was consistent with last year, reflecting strong operating cost management, offset by continued growth of the services businesses and investments to support growth. </font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">Cash flows from operations for the full year were $29.1 billion or 1.3-times net income. During 2023, the company returned $14.8 billion to shareholders through dividends and share repurchases. Return on equity of 27% in 2023 reflected the company&#8217;s strong overall growth and efficient capital structure.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 2 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:center"><img alt="uhclogowithra.jpg" src="uhclogowithra.jpg" style="height:66px;margin-bottom:5pt;vertical-align:text-bottom;width:360px"></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and consumers receive by improving health and wellness, enhancing the quality of care received, simplifying the health care experience and reducing the total cost of care.</font></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"><tr><td style="width:1.0pt"></td><td style="width:151.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:67.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:70.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly and Annual Financial Performance</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="6" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</font></td></tr><tr style="height:24pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70.8 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$63.0 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$69.9 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$281.4 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$249.7 billion</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.1 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.9 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.6 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.4 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.4 billion</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8%</font></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:15pt;padding-left:18pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">UnitedHealthcare full year revenues of $281.4 billion grew $31.6 billion or 12.7% year-over-year and operating earnings increased 14.2% to $16.4 billion.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">People served by UnitedHealthcare grew by over 1 million in 2023. </font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">The number of consumers served with commercial benefits grew by over 800,000 in 2023, reflecting the strong customer response to the company&#8217;s innovative and affordable benefit offerings. </font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">The number of people served by the company&#8217;s offerings for seniors and people with complex needs grew by 950,000 due to product designs tailored to meet the specific needs of individuals and their families with limited economic resources and who are often underserved. </font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:14.15pt">People served by the company&#8217;s state-based community offerings declined by 700,000 due to the ongoing Medicaid eligibility redetermination process. The UnitedHealthcare team remains actively engaged with the individuals impacted and continues with its comprehensive outreach to help families maintain, reinstate or find other affordable coverage.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 3 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><img alt="optumlogoforearningsreleasea.jpg" src="optumlogoforearningsreleasea.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:164px"></div><div style="margin-bottom:12pt;margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">Optum&#8217;s health services businesses serve the global health care marketplace, including payers, care providers, employers, governments, life sciences companies and consumers. Using market-leading information, analytics and technology to yield clinical insights, Optum helps improve overall health system performance by optimizing care quality, reducing care costs and improving the consumer experience.</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:507.00pt"><tr><td style="width:1.0pt"></td><td style="width:150.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:72.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:63.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="12" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quarterly and Annual Financial Performance</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</font></td><td colspan="6" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended</font></td></tr><tr style="height:20pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2023</font></td><td colspan="3" style="border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">2022</font></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$59.5 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$47.9 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$56.7 billion</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$226.6 billion</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$182.8 billion</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.6 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.0 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.9 billion</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$15.9 billion</font></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14.1 billion</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9%</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0%</font></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7%</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:15pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">Optum full year revenues of $226.6 billion grew $43.9 billion or 24% year-over-year and operating earnings increased 13.4% to $15.9 billion.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">Optum Health revenue increased 33.9% over last year, driven by growth in patients served under value-based arrangements and continued expansion of the types and levels of care provided. The operating results reflect previously noted higher care activity and continued investments to improve patient health outcomes. The number of patients served under value-based arrangements grew by nearly 900,000 to more than 4.1 million.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">Optum Insight revenue increased 29.8% due to the addition of Change Healthcare and growth in its technology-enabled offerings, which serve health systems, care providers, health plans and life sciences organizations. Optum Insight continues to build and invest in advanced data capabilities to meet the rising needs of customers. The revenue backlog increased by more than $2 billion to over $32 billion.</font></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:150%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%;padding-left:13.8pt">Optum Rx revenue increased 16.4% in 2023 due to growth in serving new clients, expanded relationships with existing clients and continued advancement in the comprehensive scope of pharmacy services offered, including specialty and community-based pharmacies. Adjusted scripts grew to 1.54 billion compared to 1.44 billion last year. </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 4 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:150%;text-decoration:underline">About UnitedHealth Group</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">UnitedHealth Group (NYSE&#58; UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">www.unitedhealthgroup.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> and follow UnitedHealth Group on </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">.</font></div><div style="margin-top:15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:150%;text-decoration:underline">Earnings Conference Call</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">As previously announced, UnitedHealth Group will discuss the Company&#8217;s results, strategy and future outlook on a conference call with investors at 8&#58;45 a.m. Eastern Time today. UnitedHealth Group will host a live webcast of this conference call from the Investor Relations page of the company&#8217;s website (</font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">www.unitedhealthgroup.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">). Following the call, a webcast replay will be on the Investor Relations page and at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">https&#58;&#47;&#47;uhg.com&#47;Replay</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%"> through January 26, 2024. This earnings release and the Form 8-K dated January 12, 2024, can also be accessed from the Investor Relations page of the company&#8217;s website.</font></div><div style="margin-top:15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:150%;text-decoration:underline">Non-GAAP Financial Information</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">This news release presents non-GAAP financial information provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). A reconciliation of the non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.</font></div><div style="margin-top:15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:150%;text-decoration:underline">Forward-Looking Statements</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">The statements, estimates, projections, guidance or outlook contained in this document include &#8220;forward-looking&#8221; statements which are intended to take advantage of the &#8220;safe harbor&#8221; provisions of the federal securities law. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;forecast,&#8221; &#8220;outlook,&#8221; &#8220;plan,&#8221; &#8220;project,&#8221; &#8220;should&#8221; and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including&#58; our ability to effectively estimate, price for and manage medical costs&#59; new or changes in existing health care laws or regulations, or their enforcement or application&#59; reductions in revenue or delays to cash flows received under government </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 5 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">programs&#59; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits&#59; the DOJ&#8217;s legal action relating to the risk adjustment submission matter&#59; our ability to maintain and achieve improvement in quality scores impacting revenue&#59; failure to maintain effective and efficient information systems or if our technology products do not operate as intended&#59; cyberattacks, other privacy&#47;data security incidents, or our failure to comply with related regulations&#59; risks and uncertainties associated with our businesses providing pharmacy care services&#59; competitive pressures, including our ability to maintain or increase our market share&#59; changes in or challenges to our public sector contract awards&#59; failure to achieve targeted operating cost productivity improvements&#59; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers&#59; the impact of potential changes in tax laws and regulations&#59; increases in costs and other liabilities associated with litigation, government investigations, audits or reviews&#59; failure to complete, manage or integrate strategic transactions&#59; risk and uncertainties associated with the pending sale of operations in Brazil&#59; risks associated with public health crises arising from large-scale medical emergencies, pandemics, natural disasters and other extreme events&#59; failure to attract, develop, retain, and manage the succession of key employees and executives&#59; our investment portfolio performance&#59; impairment of our goodwill and intangible assets&#59; failure to protect proprietary rights to our databases, software and related products&#59; downgrades in our credit ratings&#59; and our ability to obtain sufficient funds from our regulated subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of our common stock. </font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:150%">This above list is not exhaustive. We discuss these matters, and certain risks that may affect our business operations, financial condition and results of operations, more fully in our filings with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking statements are not guarantees of future performance or results and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Actual results may vary materially from expectations expressed or implied in this document or any of our prior communications. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.</font></div><div style="margin-top:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"># # #</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Investor Contact&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Media Contact&#58;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Zack Sopcak</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Eric Hausman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">952-936-7215</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">952-936-3963</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">zack.sopcak&#64;uhg.com</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#3051f2;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">eric.hausman&#64;uhg.com</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Page 6 of 6</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="ic91fe566cc574b2d96ca6eb54d06beb6_4"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Earnings Release Schedules and Supplementary Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Year Ended December&#160;31, 2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Statements of Operations</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Balance Sheets</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Condensed Consolidated Statements of Cash Flows</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Supplemental Financial Information - Businesses</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Supplemental Financial Information - Business Metrics</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:174%;padding-left:14.5pt">Reconciliation of Non-GAAP Financial Measure</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="ic91fe566cc574b2d96ca6eb54d06beb6_7"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except per share data)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.552%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended <br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$73,228</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$64,700</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$290,827</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$257,157</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,311</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,398</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,583</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,424</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,709</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,834</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,123</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,551</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,179</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,089</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenues</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,427</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,787</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,622</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324,162</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,231</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,591</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,894</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,842</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,339</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,009</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,628</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,782</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,194</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,314</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,770</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,703</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,738</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,896</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,264</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,727</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,689</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,891</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,358</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,435</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(830)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(676)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,246)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,092)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,215</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,112</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,343</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,184)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,307)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,968)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,704)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings </font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,675</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,908</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,144</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,639</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to noncontrolling interests</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(519)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net earnings attributable to UnitedHealth Group common shareholders</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,455</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,761</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,381</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,120</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share attributable to UnitedHealth Group common shareholders </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.83</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.03</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.86</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.18</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted earnings per share attributable to UnitedHealth Group common shareholders (a)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.16</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.34</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.12</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.19</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">935</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">947</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950</font></td></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">See page 6 for a reconciliation of the non-GAAP measure</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br>2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br>2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and short-term investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,628</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27,911</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,276</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,681</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,533</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,477</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,437</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,069</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,609</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,728</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,674</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,908</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$273,720</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$245,705</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, redeemable noncontrolling interests and equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32,395</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$29,056</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term borrowings and current maturities of long-term debt</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,110</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,385</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,071</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,054</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,237</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current maturities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,263</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,513</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,484</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,608</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,498</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,897</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,421</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,450</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests and equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$273,720</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$245,705</font></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.620%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended <br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23,144</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,639</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncash items&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,972</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes and other</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(750)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,004)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net changes in operating assets and liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,643</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,246</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,068</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,206</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments, net of sales and maturities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,777)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,837)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, equipment and capitalized software</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,386)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,802)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisitions, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,136)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,458)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,621</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used for investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,574)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,476)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common share repurchases</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,000)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,000)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,761)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,991)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in short-term borrowings and long-term debt</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,280</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,536</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,048)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,681</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows (used for) from financing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,529)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,226</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,990</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,365</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,375</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25,427</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23,365</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except percentages)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended <br>December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$70,808</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$63,046</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$281,360</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$249,741</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,495</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,868</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,635</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,768</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,876)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,127)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,373)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,347)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$94,427</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$82,787</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$371,622</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$324,162</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings from Operations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,122</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,932</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16,415</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$14,379</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum (a)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,567</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,959</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,943</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,056</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated earnings from operations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7,689</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,891</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32,358</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$28,435</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Margin</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating margin</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &#38; Individual - Domestic</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$17,030</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16,281</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$67,187</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$63,599</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &#38; Individual - Global</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,402</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,168</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,307</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,668</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Employer &#38; Individual - Total</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,432</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,449</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,494</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,267</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Medicare &#38; Retirement</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,394</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,051</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,862</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,671</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthcare Community &#38; State</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,982</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,546</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,004</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,803</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$24,534</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18,446</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$95,319</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$71,174</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Insight</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,785</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,932</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,581</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Rx</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,166</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,854</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,087</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,773</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum eliminations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(990)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,703)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,760)</font></td></tr></table></div><div style="margin-top:7pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">Earnings from operations for Optum for the three months and year ended December 31, 2023 included $1,691 and $6,560 for Optum Health&#59; $1,284 and $4,268 for Optum Insight&#59; and $1,592 and $5,115 for Optum Rx, respectively. Earnings from operations for Optum for the three months and year ended December 31, 2022 included $1,692 and $6,032 for Optum Health&#59; $895 and $3,588 for Optum Insight&#59; and $1,372 and $4,436 for Optum Rx, respectively.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTHCARE CUSTOMER PROFILE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in thousands)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.032%"><tr><td style="width:1.0%"></td><td style="width:52.320%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">People Served</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial - Domestic&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-based</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,115&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,120&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,045&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-based</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,200&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,130&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,640&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;Total Commercial - Domestic</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,315&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,250&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,685&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,695&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,105&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,845&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,065&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,170&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement (Standardized)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,355&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,345&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,375&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total Community and Senior</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,895&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,055&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,650&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total UnitedHealthcare - Domestic Medical</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,210&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,305&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,335&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial - Global</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,540&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,475&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,360&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total UnitedHealthcare - Medical</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,750&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,780&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,695&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental Data</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Medicare Part D stand-alone</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,315&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,335&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,295&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font><br></font></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OPTUM PERFORMANCE METRICS</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.032%"><tr><td style="width:1.0%"></td><td style="width:52.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.775%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Health Consumers Served (in millions)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Insight Contract Backlog (in billions)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$32.1</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$31.6</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$30.0</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Optum Rx Quarterly Adjusted Scripts (in millions)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note&#58; UnitedHealth Group served 152 million unique individuals across all businesses at December 31, 2023.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:6.75pt;padding-right:6.75pt;text-align:center;text-indent:-13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITEDHEALTH GROUP</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECONCILIATION OF NON-GAAP FINANCIAL MEASURE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(in millions, except per share data)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(unaudited)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ADJUSTED NET EARNINGS PER SHARE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</font></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.677%"><tr><td style="width:1.0%"></td><td style="width:65.782%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.231%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.672%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended <br>December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP net earnings attributable to UnitedHealth Group common shareholders</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,455</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,761</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22,381</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$20,120</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect of intangible amortization</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(331)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted net earnings attributable to UnitedHealth Group common shareholders</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,755</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5,059</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23,567</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21,081</font></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP diluted earnings per share</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.83</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.03</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$23.86</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.18</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible amortization per share</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.44</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.42</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect per share of intangible amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.42)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.35)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted diluted earnings per share</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6.16</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.34</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$25.12</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$22.19</font></td></tr></table></div><div style="margin-top:18pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:25.02pt">Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP. </font></div><div style="margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company&#8217;s acquisition activity, management believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company&#8217;s revenue generation, the intangible amortization is not directly related. Therefore, the related revenues are included in adjusted earnings per share.</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>unh-20240112.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b197cb2c-d9a5-468e-9558-8fe9510c2889,g:0c0038cb-9400-4966-a322-d321c163fdbd-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:unh="http://www.unitedhealthgroup.com/20240112" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.unitedhealthgroup.com/20240112">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20240112_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20240112_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20240112_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.unitedhealthgroup.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>unh-20240112_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b197cb2c-d9a5-468e-9558-8fe9510c2889,g:0c0038cb-9400-4966-a322-d321c163fdbd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.unitedhealthgroup.com/role/Cover" xlink:type="simple" xlink:href="unh-20240112.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.unitedhealthgroup.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8ab5f4ae-15a9-4aaa-a92d-9f88be43dd9c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_DocumentType_8ab5f4ae-15a9-4aaa-a92d-9f88be43dd9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2dc6fb3b-e728-48e5-bc00-d2d67cebf73d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_DocumentPeriodEndDate_2dc6fb3b-e728-48e5-bc00-d2d67cebf73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3437495f-f6b2-45ae-903f-e3383b9d016f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityRegistrantName_3437495f-f6b2-45ae-903f-e3383b9d016f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_def1536f-1cfe-4299-b2b3-b716de004bf8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_def1536f-1cfe-4299-b2b3-b716de004bf8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_20482e9b-0947-4d74-9996-3c02cafe75a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityFileNumber_20482e9b-0947-4d74-9996-3c02cafe75a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3852664c-22f8-44aa-817d-f6f368fa7cbf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityTaxIdentificationNumber_3852664c-22f8-44aa-817d-f6f368fa7cbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0719e0c4-17ce-497d-99bc-655a2038de02" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressAddressLine1_0719e0c4-17ce-497d-99bc-655a2038de02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7945931a-aec5-42fb-b648-1b556d874be0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressCityOrTown_7945931a-aec5-42fb-b648-1b556d874be0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ca39c145-a6e7-4e58-9651-590bfd0f8846" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressStateOrProvince_ca39c145-a6e7-4e58-9651-590bfd0f8846" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_77023334-40ff-4330-8c70-7827c772c482" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressPostalZipCode_77023334-40ff-4330-8c70-7827c772c482" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ccc6d2b6-ecda-4951-a1de-12393e247f34" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_CityAreaCode_ccc6d2b6-ecda-4951-a1de-12393e247f34" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_aac29898-f1b2-49f0-acd5-49a89df394e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_LocalPhoneNumber_aac29898-f1b2-49f0-acd5-49a89df394e8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_2034dba7-979a-4263-92a2-fdb8cf1156e6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_WrittenCommunications_2034dba7-979a-4263-92a2-fdb8cf1156e6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_c271bd20-403b-43ac-af4a-ff08583e7837" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_SolicitingMaterial_c271bd20-403b-43ac-af4a-ff08583e7837" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4fffde2f-b889-4553-8473-b35526104b00" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_PreCommencementTenderOffer_4fffde2f-b889-4553-8473-b35526104b00" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e0d10c5e-6263-40a1-b0b2-08afe7aad934" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e0d10c5e-6263-40a1-b0b2-08afe7aad934" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ac321fe4-3194-4a82-a0b4-38740d77ef67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_Security12bTitle_ac321fe4-3194-4a82-a0b4-38740d77ef67" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_800faf26-4e25-4c10-94a2-b80e692438e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_TradingSymbol_800faf26-4e25-4c10-94a2-b80e692438e4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c418c8fd-6abf-4ef0-a767-b3c922f9d0c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_SecurityExchangeName_c418c8fd-6abf-4ef0-a767-b3c922f9d0c0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5c6f41ea-7065-41a3-9561-f4e85f692185" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityEmergingGrowthCompany_5c6f41ea-7065-41a3-9561-f4e85f692185" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_19424c6e-3d6e-4c76-9640-9936bd2a97d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityCentralIndexKey_19424c6e-3d6e-4c76-9640-9936bd2a97d3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_de17a284-3235-45b0-b492-edeb241bdd60" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_AmendmentFlag_de17a284-3235-45b0-b492-edeb241bdd60" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_332a13e7-ad03-47a1-a0d4-39478dd40981" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_DocumentInformationTable_332a13e7-ad03-47a1-a0d4-39478dd40981" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_f486e6e0-f12e-42b0-9c02-58ad247f83e1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_332a13e7-ad03-47a1-a0d4-39478dd40981" xlink:to="loc_dei_DocumentInformationDocumentAxis_f486e6e0-f12e-42b0-9c02-58ad247f83e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_f486e6e0-f12e-42b0-9c02-58ad247f83e1_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_DocumentInformationDocumentAxis_f486e6e0-f12e-42b0-9c02-58ad247f83e1" xlink:to="loc_dei_DocumentDomain_f486e6e0-f12e-42b0-9c02-58ad247f83e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_36cd7894-b1eb-4d04-9793-143570b6c038" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_DocumentInformationDocumentAxis_f486e6e0-f12e-42b0-9c02-58ad247f83e1" xlink:to="loc_dei_DocumentDomain_36cd7894-b1eb-4d04-9793-143570b6c038" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>unh-20240112_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b197cb2c-d9a5-468e-9558-8fe9510c2889,g:0c0038cb-9400-4966-a322-d321c163fdbd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentPeriodEndDate_7782437f-c367-4432-acde-022b8fda4659_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_058056c2-b44d-4c26-b218-a686cd9a9ee3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c6dd8fa7-843e-4296-bb94-7ecee9cb05dd_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6f7ab12a-a4e5-4467-a26b-a1e73d9a3cdb_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c68e996f-4fea-4c04-9847-0250c1921718_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_742b010a-a485-4371-b334-2f68dcf4e9db_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentDomain_8cf923d8-887f-483d-81b4-4a6f548b7872_terseLabel_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:label id="lab_dei_DocumentDomain_label_en-US" xlink:label="lab_dei_DocumentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentDomain" xlink:to="lab_dei_DocumentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_97545ea2-475b-4179-b276-3642567a069d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_91d208f2-de8d-44e9-9e50-d113f628ca88_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d2bd4958-b2ca-47a8-8933-fba1496280f5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_0d5cc41a-03ad-4afb-a364-c94a8105e403_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_5abe1e77-d50f-4a74-8dd7-ebbb922b1d39_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e24f11f6-3510-433b-bbea-83d756f34d9e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_02c45310-0f71-4301-9771-966c202e0b6b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_54d111bb-9286-49c2-a69f-179df833d7d9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_06cd5aa6-ac2e-44dd-9a74-1eb084fa2961_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f15cce89-0625-4c87-8af4-7c820bddefad_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_92dc4e2c-7d8a-46d6-9abd-be3db42278c0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_9ce6d1cb-ceda-44f4-808c-a33cb04f1827_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:label id="lab_dei_DocumentInformationDocumentAxis_label_en-US" xlink:label="lab_dei_DocumentInformationDocumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information, Document [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationDocumentAxis" xlink:to="lab_dei_DocumentInformationDocumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e697a8ca-28c5-4a3c-a4a4-f2dd003e029c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fb1a8b98-9a65-44f1-af6d-e9fbb5df668b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_979f3732-f273-4697-8450-300b6530c9de_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_932613d8-f65f-4c28-92a6-a2df19d61e58_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2898efce-3da7-4c7c-9fb5-9c97c8eb59b2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_8fc6eb0d-4be6-4122-a9c1-99a0996595fa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_034d029c-4420-4e81-b0f9-1e09ad32a977_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>unh-20240112_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b197cb2c-d9a5-468e-9558-8fe9510c2889,g:0c0038cb-9400-4966-a322-d321c163fdbd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.unitedhealthgroup.com/role/Cover" xlink:type="simple" xlink:href="unh-20240112.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.unitedhealthgroup.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cbab90d8-ecfe-4f5e-b357-c586d731eb69" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_332a13e7-ad03-47a1-a0d4-39478dd40981" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cbab90d8-ecfe-4f5e-b357-c586d731eb69" xlink:to="loc_dei_DocumentInformationTable_332a13e7-ad03-47a1-a0d4-39478dd40981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationDocumentAxis_f486e6e0-f12e-42b0-9c02-58ad247f83e1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationDocumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_332a13e7-ad03-47a1-a0d4-39478dd40981" xlink:to="loc_dei_DocumentInformationDocumentAxis_f486e6e0-f12e-42b0-9c02-58ad247f83e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentDomain_36cd7894-b1eb-4d04-9793-143570b6c038" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationDocumentAxis_f486e6e0-f12e-42b0-9c02-58ad247f83e1" xlink:to="loc_dei_DocumentDomain_36cd7894-b1eb-4d04-9793-143570b6c038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_332a13e7-ad03-47a1-a0d4-39478dd40981" xlink:to="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8ab5f4ae-15a9-4aaa-a92d-9f88be43dd9c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_DocumentType_8ab5f4ae-15a9-4aaa-a92d-9f88be43dd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_2dc6fb3b-e728-48e5-bc00-d2d67cebf73d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_DocumentPeriodEndDate_2dc6fb3b-e728-48e5-bc00-d2d67cebf73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3437495f-f6b2-45ae-903f-e3383b9d016f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityRegistrantName_3437495f-f6b2-45ae-903f-e3383b9d016f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_def1536f-1cfe-4299-b2b3-b716de004bf8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_def1536f-1cfe-4299-b2b3-b716de004bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_20482e9b-0947-4d74-9996-3c02cafe75a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityFileNumber_20482e9b-0947-4d74-9996-3c02cafe75a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3852664c-22f8-44aa-817d-f6f368fa7cbf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityTaxIdentificationNumber_3852664c-22f8-44aa-817d-f6f368fa7cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0719e0c4-17ce-497d-99bc-655a2038de02" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressAddressLine1_0719e0c4-17ce-497d-99bc-655a2038de02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7945931a-aec5-42fb-b648-1b556d874be0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressCityOrTown_7945931a-aec5-42fb-b648-1b556d874be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_ca39c145-a6e7-4e58-9651-590bfd0f8846" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressStateOrProvince_ca39c145-a6e7-4e58-9651-590bfd0f8846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_77023334-40ff-4330-8c70-7827c772c482" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityAddressPostalZipCode_77023334-40ff-4330-8c70-7827c772c482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ccc6d2b6-ecda-4951-a1de-12393e247f34" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_CityAreaCode_ccc6d2b6-ecda-4951-a1de-12393e247f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_aac29898-f1b2-49f0-acd5-49a89df394e8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_LocalPhoneNumber_aac29898-f1b2-49f0-acd5-49a89df394e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_2034dba7-979a-4263-92a2-fdb8cf1156e6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_WrittenCommunications_2034dba7-979a-4263-92a2-fdb8cf1156e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_c271bd20-403b-43ac-af4a-ff08583e7837" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_SolicitingMaterial_c271bd20-403b-43ac-af4a-ff08583e7837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4fffde2f-b889-4553-8473-b35526104b00" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_PreCommencementTenderOffer_4fffde2f-b889-4553-8473-b35526104b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_e0d10c5e-6263-40a1-b0b2-08afe7aad934" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_e0d10c5e-6263-40a1-b0b2-08afe7aad934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ac321fe4-3194-4a82-a0b4-38740d77ef67" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_Security12bTitle_ac321fe4-3194-4a82-a0b4-38740d77ef67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_800faf26-4e25-4c10-94a2-b80e692438e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_TradingSymbol_800faf26-4e25-4c10-94a2-b80e692438e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c418c8fd-6abf-4ef0-a767-b3c922f9d0c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_SecurityExchangeName_c418c8fd-6abf-4ef0-a767-b3c922f9d0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5c6f41ea-7065-41a3-9561-f4e85f692185" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityEmergingGrowthCompany_5c6f41ea-7065-41a3-9561-f4e85f692185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_19424c6e-3d6e-4c76-9640-9936bd2a97d3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_EntityCentralIndexKey_19424c6e-3d6e-4c76-9640-9936bd2a97d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_de17a284-3235-45b0-b492-edeb241bdd60" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_befb5abc-2e98-4d79-b38c-034aeb949d6e" xlink:to="loc_dei_AmendmentFlag_de17a284-3235-45b0-b492-edeb241bdd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>optumlogoforearningsreleasea.jpg
<TEXT>
begin 644 optumlogoforearningsreleasea.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-I;7!S;VXL
M($UA<F-U<R!*   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,P
M-   DI(  @    ,P-   ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M( Y.*;O3^\OYT .HI RDX# _C2T %%%% !1110 4444 %%%% !1110 4444
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M.O@YPI[_ .3N>Q44R&>*YA66WD62-AD,AR#5+6-;L]$L7N+R4 @?)&#\SGT
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MM@RRWK->2KSAAA ?IWKK418T"HH55&  , 5ZN%RMI\U;[CY_'Y_%Q=/"_?\
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>uhclogowithra.jpg
<TEXT>
begin 644 uhclogowithra.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1$ 17AI9@  34T *@    @ ! $[  (
M   2   (2H=I  0    !   (7)R=  $    D   0U.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %-I;7!S;VXL
M($UA<F-U<R!*   %D ,  @   !0  !"JD 0  @   !0  !"^DI$  @    ,P
M,@  DI(  @    ,P,@  ZAP !P  " P   B>     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(O$NOL<Q@GV _)(.J\C^596;5R[FC1112 **** "BBN9\:^(-=\/6,5SX?\
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M(_\ L%7/_HIJ^<O@9J%GH7Q4*:M=16OF6\MLKR, IDW*0,GCG:<>IP.]>_\
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M=.*J_=:QO3C34GR$]%%%<1N%%%% 'G7Q,^'/AWQ*HU/4;#4!=1J=]SI:AI6
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MO3[D:Y(4>PR?SKI**?MJG\S^\.2/8Y+_ (59X'_Z%FP_[X/^-;\NBZ=-H?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>uhglogoa.jpg
<TEXT>
begin 644 uhglogoa.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  2     $  0!(     0 !_^(,6$E#0U]04D]&24Q%  $!   ,2$QI
M;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#
M('-21T(                  /;6  $     TRU(4" @
M                                               18W!R=    5
M   S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD
M9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4
M;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P
M  @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y
M-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                     %A96B
M      #S40 !     1;,6%E:(                     !865H@
M;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /
MA   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M     !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                    9&5S8P         N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M       N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="                             &1E<V,         +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ                                  !V:65W       3I/X %%\N
M !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M         0                        */     G-I9R      0U)4(&-U
M<G8        $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\
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M[D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?
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M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X $T%D;V)E &0
M     04  DE$_]L A  " @(" @(" @(" P(" @,$ P,# P0%! 0$! 0%!04%
M!04%!04%!P@(" <%"0H*"@H)# P,# P,# P,# P,# P, 0," @,# P<%!0<-
M"PD+#0\-#0T-#P\,# P,# \/# P,# P,#PP.#@X.#@P1$1$1$1$1$1$1$1$1
M$1$1$1$1$1'_P  1" !% 9@# 1$  A$! Q$!_\0!H@    <! 0$! 0
M    ! 4# @8!  <("0H+ 0 " @,! 0$! 0         !  (#! 4&!P@)"@L0
M  (! P,"! (&!P,$ @8"<P$" Q$$  4A$C%!408382)Q@10RD:$'%;%"(\%2
MT>$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5&
MI+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX*3E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^A$
M @(! @,%!00%!@0( P-M 0 "$0,$(1(Q0051$V$B!G&!D3*AL? 4P='A(T(5
M4F)R\3,D-$."%I)3):)CLL('<](UXD2#%U23" D*&!DF-D4:)V1T53?RH[/#
M*"G3X_.$E*2TQ-3D]&5UA96EM<75Y?5&5F9VAI:FML;6YO9'5V=WAY>GM\?7
MY_<X2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H
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M )S+\I>>_P#G(WS+_P X\:?Y2U2UOO+]UJVG+K<LL1AGO-%+K=H;<#DB<H9
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M@&9_8<)3[!G&(LD3 ^UUOM#DC#VBQRD: ,"3\0_6_P#Z&F_YQO\ _+X^2O\
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MW*L&I/I=M'8W"FG<2VS C-#VWCE#M#*#_.)^9MZ/L#+')V;A(_F@?(4^*?\
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M>,"BG=(FI\(V7MG8^U_H[-Q0/.Q]D2\/[%?O.ULTX\J/VR%(+\K/_DI^J?\
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MNK@K5J!I'/%23Q0*M32N:'M/7SUFIEEEU^P='HNRNSH:'2QPQZ=>\]2^0_\
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MOA*UHU5&)[4=HX-9JQ/$; B!?+J3^ES/9'LO4:'1&&843(FKOH!T]SPC2_\
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M,L5P=2O[.[M#<Q,L3&#T5M=8U!F8R!10Q\>-:L-LU':6G[%C@)P9)&70;_I
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M_:SJ%QJNI_7;6TU1K,2B.*&T6X>.12$CA4L$)3FS<2P^(S[?[<EJM698I$1
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M'EG0ZW4]B=J 3G,PE^.>Q!>9[/TO;_9!./' 3A[_ +MP0D/Y@_E%_P YB_\
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MC32QVS75U9J(DN8))6CA;U(5$<T3LH8 FI+$9'L3MW3QTITNI^@\CW6S[?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139632398357872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jan. 12, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 12,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">UNITEDHEALTH GROUP INCORPORATED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-10864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">41-1321939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">UnitedHealth Group Center, 9900 Bren Road East,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minnetonka,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">55343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">936-1300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">UNH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000731766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>unh-20240112_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="unh-20240112.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000731766</identifier>
        </entity>
        <period>
            <startDate>2024-01-12</startDate>
            <endDate>2024-01-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000731766</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-01-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">UNITEDHEALTH GROUP INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">1-10864</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">41-1321939</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">UnitedHealth Group Center, 9900 Bren Road East,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Minnetonka,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">55343</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">952</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">936-1300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, $.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">UNH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ +3 L6*K$(A8S 0  (@(   \
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M4$L! A0#%     @ +3 L6-JY>,#N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ +3 L6)E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    "  M,"Q8;*+38V($  "F$   &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ +3 L6)^@&_"Q @  X@P
M  T              ( !I0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  M
M,"Q8EXJ[',     3 @  "P              @ &!#P  7W)E;',O+G)E;'-0
M2P$"% ,4    "  M,"Q8JL0B%C,!   B @  #P              @ %J$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ +3 L6"0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ +3 L6&60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="unh-20240112.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.unitedhealthgroup.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="unh-20240112.htm">unh-20240112.htm</File>
    <File>unh-20240112.xsd</File>
    <File>unh-20240112_def.xml</File>
    <File>unh-20240112_lab.xml</File>
    <File>unh-20240112_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "unh-20240112.htm": {
   "nsprefix": "unh",
   "nsuri": "http://www.unitedhealthgroup.com/20240112",
   "dts": {
    "inline": {
     "local": [
      "unh-20240112.htm"
     ]
    },
    "schema": {
     "local": [
      "unh-20240112.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "unh-20240112_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "unh-20240112_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "unh-20240112_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 27,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.unitedhealthgroup.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "unh-20240112.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "unh-20240112.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document [Domain]",
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information, Document [Axis]",
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.unitedhealthgroup.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000731766-24-000023-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000731766-24-000023-xbrl.zip
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M/!JBAQ'?%,AGZ'_O$#:ZV;"4)4-\<A)B&S]VR'MGG! W</QA0D;.F+FI KW
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MW#VO!TJW)'O#C(CM DI53<G4!$FM1TJQ5<F:HZGC%9DO W_HARS+^,%]]AI
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M2EI7>$RL1TF1#,L6.%7 2>VV1<2_=[X3&"EU4Q+UB;]#/MTN#X!W\(_PNJF
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MJ8^QS:*2R\=22YDW5QFN]>OX!AH,><10D74I:)2BGJ@$14-_9E,S.IIMENU
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M:Y[[/.<>:X[QD#^R?6C ]P_L+FZ3@KL?:=XV8#<ZO/<J<*<(^&!Q1L&,LRP
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M9+U%'T/OYX?2+O ,RRW7..MS@:F6.4J<-)Q  ,<EKO&"2ANJ'YD[ *#[AV\
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M251P8OKRYM7]Z?Y/_[[9FU?_!5!+ P04    "  M,"Q8NFK1%[<+  #,;
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M\/+(7#\8IM,;W5W+T2!X.?].2US7I]<O[C]H']H_.[Y^\3]02P$"% ,4
M"  M,"Q8-TT;I_PW   S9@, %0              @ $     83(P,C-Q-&5X
M:&EB:70Y.3$N:'1M4$L! A0#%     @ +3 L6+C[ZBKV#@  GW0  !
M         ( !+S@  '5N:"TR,#(T,#$Q,BYH=&U02P$"% ,4    "  M,"Q8
M8&2DJ7P"  "%"   $               @ %31P  =6YH+3(P,C0P,3$R+GAS
M9%!+ 0(4 Q0    ( "TP+%B*1LN6S@<  &HX   4              "  ?U)
M  !U;F@M,C R-# Q,3)?9&5F+GAM;%!+ 0(4 Q0    ( "TP+%BZ:M$7MPL
M ,QL   4              "  ?U1  !U;F@M,C R-# Q,3)?;&%B+GAM;%!+
M 0(4 Q0    ( "TP+%AP/2KX> <  +PZ   4              "  >9=  !U
I;F@M,C R-# Q,3)?<')E+GAM;%!+!08     !@ & (4!  "090     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
